A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure
Feasibility of Assessing Wound Perfusion at the Time of Laparotomy Closure
1 other identifier
interventional
20
1 country
8
Brief Summary
This study is being done to find out if Spectrum Near-Infrared (NIR) imaging with Indocyanine Green (ICG) dye can help measure blood flow around an incision before and after the surgeon closes the incision with staples or sutures. The Spectrum NIR imaging system uses a handheld camera that produces a special type of light that can help surgeons see things during surgery that are difficult to see with the naked eye, for example, cancer tissue versus healthy tissue. Spectrum NIR imaging has been approved by the Food and Drug Administration (FDA) as a tool that is widely used during surgery. ICG dye is a sterile solution that can be seen with Spectrum NIR imaging. This dye, used with Spectrum NIR imaging, allows surgeons to see blood flow to parts of the body during and after surgery. Making sure that there is enough blood flow to the surgical site helps to promote a less complicated recovery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2018
CompletedFirst Submitted
Initial submission to the registry
January 17, 2018
CompletedFirst Posted
Study publicly available on registry
January 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedAugust 2, 2022
August 1, 2022
4.5 years
January 17, 2018
August 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage of cases with successful perfusion measurements
Feasibility will be determined by the percentage of cases with successful perfusion measurements.
1 year
Study Arms (1)
Women having a Laparotomy
EXPERIMENTALThe first 10 patients enrolled will undergo skin closure with staples. The next 10 patients enrolled will undergo skin closure with a running subcuticular suture.to evaluate skin perfusion using the Spectrum NIR imaging system following intravenous injection of ICG in all patients. Patients will be assigned skin closure with either running subcuticular suture or skin staples in a sequential, nonrandomized fashion before the procedure. After the planned surgical procedure is complete, ICG will be injected intravenously. Video of the incision will be recorded. After skin closure is complete, a second intravenous bolus of ICG (same dose as previously injected) will be given. Video of the incision will again be recorded. Measurement of perfusion will subsequently be performed by video analysis at the previously described three predefined points along the incision after surgery is complete and again after skin closure.
Interventions
Laparotomy via vertical midline incision and after the planned surgical procedure is complete.
ICG will be injected intravenously ICG is a fluorescent iodide dye.
The Spectrum NIR imaging system uses a handheld camera that emits light in the NIR range.
Eligibility Criteria
You may qualify if:
- Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK
- Age ≥18 years
You may not qualify if:
- Women with hepatic dysfunction as evidenced by elevated transaminases
- Women with a history of cirrhosis or other chronic liver disease
- Women with an allergy to iodine
- Women undergoing laparoscopic or minimally invasive surgery
- Criteria for Eligibility Post-Surgery
- Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK
- Age ≥18 years
- Women with laparotomy incisions unable to be closed primarily due to tissue or fascial damage
- Women with transverse laparotomy incisions
- Women with laparotomy incisions left open due to a case classification as "contaminated" or "dirty"
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Memoral Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, New Jersey, 07920, United States
Memoral Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, 07748, United States
Memorial Sloan Kettering Bergen (Consent only )
Montvale, New Jersey, 07645, United States
Memorial Sloan Kettering Commack (Consent only)
Commack, New York, 11725, United States
Memoral Sloan Kettering Westchester (Consent only)
Harrison, New York, 10604, United States
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Memorial Sloan Kettering Rockville Centre (Consent only)
Rockville Centre, New York, 11570, United States
Memorial Sloan Kettering Nassau (Consent only)
Uniondale, New York, 11553, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nadeem Abu-Rustum, MD
Memorial Sloan Kettering Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2018
First Posted
January 24, 2018
Study Start
January 15, 2018
Primary Completion
August 1, 2022
Study Completion
August 1, 2022
Last Updated
August 2, 2022
Record last verified: 2022-08